NCT03681808View on ClinicalTrials.gov

Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions
Astigmatism
Interventions
DEVICE

Control

Contact Lens

DEVICE

Test

Soft Contact Lens

Trial Locations (13)

10022

Bausch Site 118, New York

10036

Bausch Site 111, New York

14618

Bausch Site 110, Brighton

27603

Bausch Site 114, Raleigh

32250

Bausch Site 102, Jacksonville

61701

Bausch Site 116, Bloomington

77204

Bausch Site 105, Houston

92123

Bausch Site 107, San Diego

92618

Bausch Site 117, Irvine

94087

Bausch Site 104, Sunnyvale

94112

Bausch Site 101, San Francisco

95132

Bausch Site 108, San Jose

98027

Bausch Site 115, Issaquah

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT03681808 - Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism | Biotech Hunter | Biotech Hunter